Werewolf Therapeutics Inc (HOWL) with a beta value of 0.37 appears to be a promising investment opportunity.
On Tuesday, Werewolf Therapeutics Inc (NASDAQ: HOWL) was 14.29% up from the session before settling in for the closing price of $1.33. A 52-week range